ALNY Alnylam Pharmaceuticals, Inc.
Healthcare$297.45-1.02%ClosedMarket Cap: $39.71B
As of 2026-05-25
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
 PBE | Invesco Biotechnology & Genome ETF | 38,706 | 5.11% |
 BBH | VanEck Biotech ETF | 46,120 | 4.11% |
 IBB | iShares Biotechnology ETF | 979,642 | 3.98% |
 FDGFDGFDG | 29,103 | 3.76% | |
 FDG | American Century Focused Dynamic Growth ETF | 22,698 | 2.46% |
 ACFNX | 117,298 | 2.44% | |
 HTEC | ROBO Global Healthcare Technology and Innovation ETF | 11,632 | 1.53% |
 CAML | Congress Large Cap Growth ETF | 15,639 | 1.50% |
 IWP | iShares Russell Mid-Cap Growth ETF | 850,606 | 1.49% |
 NIW | 850,606 | 1.49% | |
 VMGRX | 110,132 | 1.43% | |
 VGHAX | 1,309,033 | 1.31% | |
 VGHCX | 1,309,033 | 1.31% | |
 XBI | 264,406 | 1.21% | |
 VMGIX | 1,096,943 | 1.15% | |
 VOT | 1,096,943 | 1.15% | |
 VMGMX | 1,096,943 | 1.15% | |
 PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 24,041 | 1.12% |
 TWCUX | American Century Ultra Investor Class | 747,000 | 1.11% |
 TWHIX | American Century Heritage Investor Class | 155,241 | 1.09% |